Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha